Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines. [electronic resource]
Producer: 20091224Description: 5906-10 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Anthracyclines -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Canada
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Humans
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Prospective Studies
- Stroke Volume -- drug effects
- Time Factors
- Treatment Outcome
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.